(Q36292511)

13 August 2017

Frequent alterations of cell cycle regulators in early-stage breast lesions as detected by immunohistochemistry (English)

1 reference

13 August 2017

1 reference

Marsh KL

1

1 reference

13 August 2017

Varley JM

series ordinal

2

1 reference

13 August 2017

language of work or name

English

0 references

publication date

1 May 1998

1 reference

British Journal of Cancer

13 August 2017

1 reference

13 August 2017

77

1 reference

13 August 2017

9

1 reference

13 August 2017

1460-1468

1 reference

describes a project that uses

13 August 2017

1 reference

https://scigraph.springernature.com/pub.10.1038/bjc.1998.240

0 references

cites work

A clinicopathological study on overexpression of cyclin D1 and of p53 in a series of 248 patients with operable breast cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2150197

Cyclin D1 is an essential mediator of apoptotic neuronal cell death.

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2150197

Prognostic significance of CCND1 (cyclin D1) overexpression in primary resected non-small-cell lung cancer

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2150197

Cyclin D1 expression is regulated by the retinoblastoma protein

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2150197

Aberrant RB gene expression in routinely processed, archival tumor tissues determined by three different anti-RB antibodies

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2150197

Transcriptional repression of the D-type cyclin-dependent kinase inhibitor p16 by the retinoblastoma susceptibility gene product pRb.

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2150197

Association between RB-1 gene alterations and factors of favourable prognosis in human breast cancer, without effect on survival

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2150197

Abnormalities in structure and expression of the human retinoblastoma gene in SCLC.

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2150197

The retinoblastoma gene is frequently altered leading to loss of expression in primary breast tumours.

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2150197

Stable overexpression of cyclin D1 in a human mammary epithelial cell line prolongs the S-phase and inhibits growth.

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2150197

Reciprocal Rb inactivation and p16INK4 expression in primary lung cancers and cell lines.

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2150197

Chromosome 9p allelic loss and p16/CDKN2 in breast cancer and evidence of p16 inactivation in immortal breast epithelial cells

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2150197

Cyclin D2 is a moderately oscillating nucleoprotein required for G1 phase progression in specific cell types

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2150197

Overexpression of cyclin D1 blocks proliferation of normal diploid fibroblasts

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2150197

Alternate splicing produces a novel cyclin D1 transcript.

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2150197

Cyclin D1 provides a link between development and oncogenesis in the retina and breast.

29 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2150197

Cyclin D1 and prognosis in human breast cancer

29 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2150197

CDKN2/p16 or RB alterations occur in the majority of glioblastomas and are inversely correlated.

22 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2150197

Lack of p16INK4 or retinoblastoma protein (pRb), or amplification-associated overexpression of cdk4 is observed in distinct subsets of malignant glial tumors and cell lines

22 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2150197

Homozygous deletion of the MTS1/p16 and MTS2/p15 genes and amplification of the CDK4 gene in glioma.

22 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2150197

Amplification of genes within the chromosome 11q13 region is indicative of poor prognosis in patients with operable breast cancer

22 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2150197

Loss of expression of the p16/cyclin-dependent kinase inhibitor 2 tumor suppressor gene in melanocytic lesions correlates with invasive stage of tumor progression

21 October 2018

1 reference

12 December 2020

Overexpression of cyclin D mRNA distinguishes invasive and in situ breast carcinomas from non-malignant lesions

1 reference

12 December 2020

Gene amplification on chromosome band 11q13 and oestrogen receptor status in breast cancer

1 reference

12 December 2020

D11S287, a putative oncogene on chromosome 11q13, is amplified and expressed in squamous cell and mammary carcinomas and linked to BCL-1

1 reference

12 December 2020

The retinoblastoma gene in breast cancer: allele loss is not correlated with loss of gene protein expression

1 reference

12 December 2020

Expression and amplification of cyclin genes in human breast cancer

1 reference

12 December 2020

Cyclin D1 protein oscillates and is essential for cell cycle progression in human tumour cell lines

1 reference

12 December 2020

Cyclin D1 protein expression and function in human breast cancer

1 reference

12 December 2020

Absence of cyclin D/cdk complexes in cells lacking functional retinoblastoma protein

1 reference

12 December 2020

Cyclin D1 oncoprotein aberrantly accumulates in malignancies of diverse histogenesis

1 reference

12 December 2020

Mutation spectrum of the retinoblastoma gene in osteosarcomas

1 reference

12 December 2020

Amplification and overexpression of the cyclin D1 gene in aggressive human hepatocellular carcinoma

1 reference

12 December 2020

Mutational analysis of CDKN2 (MTS1/p16ink4) in human breast carcinomas

1 reference

12 December 2020

Absence of p16INK4 protein is restricted to the subset of lung cancer lines that retains wildtype RB

1 reference

12 December 2020

Increased p16 levels correlate with pRb alterations in human urothelial cells

1 reference

12 December 2020

Expression of cyclin D1 and EMS1 in bladder tumours; relationship with chromosome 11q13 amplification

1 reference

12 December 2020

Human cyclin D1 oncogene and esophageal squamous cell carcinoma

1 reference

12 December 2020

Differential expression of the cyclin-dependent kinase inhibitors p16 and p21 in the human melanocytic system

1 reference

12 December 2020

Enhanced protein stability: a novel mechanism of D-type cyclin over-abundance identified in human sarcoma cells

1 reference

12 December 2020

1 reference

12 December 2020

Identifiers

DOI

10.1038/BJC.1998.240

1 reference

13 August 2017

1 reference

13 August 2017

PubMed publication ID

9652762

1 reference